Clinical Care

It is possible to live a relatively normal life with RUNX1 FPD/AML.  Some carriers of the disorder never go on to develop leukemia, and merely live with impaired function and/or lower platelet count, while yet others go on to develop cancer.  With appropriate management of the disorder, a healthy lifestyle, and active surveillance, people with RUNX1 FPD/AML can have a better outcome.